Success of Harvard Pilgrim Value-Based Pharma Contracts Might Indicate a Transition Away from Fee-for-Service to Value-Based Care in Other Healthcare Areas

New value-based healthcare payment models could have far-reaching effects on medical laboratories and the testing they provide Hospitals, physicians, and medical laboratories recognize the transition from “volume to value” that’s underway in the American healthcare system. Fee-for-service payments for clinical services (regardless of whether they are needed or effective) will soon cease and providers will be increasingly paid on how much value they deliver to patient care. This will...

After Taking on Jeopardy Contestants, IBM’s Watson Super Computer Might Be a Resource for Pathologists

Watson is capable of assessing health data, including medical laboratory test results When IBM’s Watson “supercomputer” squared off against human contestants on the Jeopardy game show last February, there certainly were some pathologists and clinical laboratory managers watching this “man versus machine” battle of knowledge. But those pathologists and medical lab managers did not realize that IBM intends for Watson to play a major role in helping physicians diagnose and treat disease. IBM is...
;